223433-79-2

Basic information

• Product Name: 2-amino-5-(4-chloro-phenoxy)-3H-pyrimidin-4-one
• Synonyms: 2-amino-5-(4-chloro-phenoxy)-3H-pyrimidin-4-one
• CAS NO: 223433-79-2
• Molecular Weight: 237.645
• Mol File: 223433-79-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-amino-5-(4-chloro-phenoxy)-3H-pyrimidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-amino-5-(4-chloro-phenoxy)-3H-pyrimidin-4-one(223433-79-2)
• EPA Substance Registry System: 2-amino-5-(4-chloro-phenoxy)-3H-pyrimidin-4-one(223433-79-2)

Safety Data

• Hazardous Substances Data: 223433-79-2(Hazardous Substances Data)

Upstream product

• 14426-42-7 ethyl p-chlorophenoxyacetate 

Downstream Products

• 223433-91-8 4-(4-acetylpiperazino)-2-amino-5-(4-chlorophenoxy)pyrimidine 
• 223433-84-9 2-amino-5-(4-chlorophenoxy)-4-(4-formylpiperazino)pyrimidine 
• 223433-88-3 2-amino-5-(4-chlorophenoxy)-4-(2-(2-hydroxyethoxy)ethylamino)pyrimidine hydrochloride 
• 223433-86-1 2-amino-5-(4-chlorophenoxy)-4-(4-(2-hydroxyethyl)piperazino)pyrimidine 
• 223433-87-2 2-amino-5-(4-chlorophenoxy)-4-(4-methylpiperazino)pyrimidine 
• 223433-81-6 2-amino-5-(4-chlorophenoxy)-4-(piperazino)pyrimidine 
• 223433-89-4 2-Amino-4-(4-carbamoylpiperidino)-5-(4-chlorophenoxy)pyrimidine 
• 301526-80-7 4chloro-5-(4chlorophenoxy)-2-(diisopropylaminomethyleneamino)-pyrimidine 
• 7331-20-6 5-(4-chloro-phenoxy)-pyrimidine-2,4-diamine 
• 223433-90-7 2-amino-5-(4-chlorophenoxy)-4-(morpholino)pyrimidine 

Relevant articles and documents

Neurotrophic substituted pyrimidines

The present invention relates to a series of substituted pyrimidines, to pharmaceutical compositions which contain them, to methods for their preparation and to their use in therapy, particularly in the treatment of neurodegenerative or other neurological

Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system

The present invention relates to novel derivatives of a series of substituted pyrimidines, to pharmaceutical compositions which contain them, to methods for their preparation and to their use in therapy, particularly in the treatment of neurodegenerative